| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2013 | EGFR polymorphisms, hormone replacement therapy, and lung adenocarcinoma risk: analysis from a genome-wide association study in never-smoking women | Chen, KY; Hsiao, CF; Chang, GC; Tsai, YH; Su, WC; Chen, YM; Huang, MS; Hsiung, CA; Chen, CJ; Yang, PC; GELAC Study Group | Carcinogenesis 34(3), 612-619 | | | |
| 2015 | Estrogen Receptor Gene Polymorphisms and Lung Adenocarcinoma Risk in Never-Smoking Women | Chen, KY; Hsiao, CF; Chang, GC; Tsai, YH; Su, WC; Chen, YM; Huang, MS; Hsiung, CA; Chen, CJ; Yang, PC; GELAC Study Group | J Thorac Oncol 10(10), 1413-1420 | | | |
| 2021 | Programmed Death Ligand 2 Gene Polymorphisms Are Associated With Lung Adenocarcinoma Risk in Female Never-Smokers | Liang, SK; Chien, LH; Chang, GC; Tsai, YH; Su, WC; Chen, YM; Huang, MS; Lin, HC; Fang, WT; Hung, HH; Jiang, SS; Chen, CY; Chen, KY; Chang, IS; Hsiung, CA; Chen, CJ ; Yang, PC; GELAC Study Group | Frontiers in oncology 11, 753788 | | | |
